NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Axsome Therapeutics Inc (NASDAQ: AXSM)

 
AXSM Technical Analysis
5
As on 9th Jun 2023 AXSM STOCK Price closed @ 73.74 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 39.68 & Strong Buy for SHORT-TERM with Stoploss of 31.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AXSMSTOCK Price

Open 75.04 Change Price %
High 75.80 1 Day -1.50 -1.99
Low 73.12 1 Week -0.04 -0.05
Close 73.74 1 Month 2.58 3.63
Volume 421900 1 Year 35.93 95.03
52 Week High 80.22 | 52 Week Low 21.74
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
AXSM
Daily Charts
AXSM
Intraday Charts
Whats New @
Bazaartrend
AXSM
Free Analysis
 
AXSM Important Levels Intraday
RESISTANCE78.90
RESISTANCE77.25
RESISTANCE76.22
RESISTANCE75.20
SUPPORT72.28
SUPPORT71.26
SUPPORT70.23
SUPPORT68.58
 
AXSM Forecast May 2024
4th UP Forecast98.12
3rd UP Forecast90.3
2nd UP Forecast85.47
1st UP Forecast80.63
1st DOWN Forecast66.85
2nd DOWN Forecast62.01
3rd DOWN Forecast57.18
4th DOWN Forecast49.36
 
AXSM Weekly Forecast
4th UP Forecast82.24
3rd UP Forecast79.51
2nd UP Forecast77.83
1st UP Forecast76.14
1st DOWN Forecast71.34
2nd DOWN Forecast69.65
3rd DOWN Forecast67.97
4th DOWN Forecast65.24
 
AXSM Forecast2024
4th UP Forecast193.64
3rd UP Forecast155.19
2nd UP Forecast131.42
1st UP Forecast107.65
1st DOWN Forecast39.83
2nd DOWN Forecast16.06
3rd DOWN Forecast-7.71
4th DOWN Forecast-46.16
 
 
AXSM Other Details
Segment EQ
Market Capital 1493710464.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
AXSM Address
AXSM
 
AXSM Latest News
 
Your Comments and Response on Axsome Therapeutics Inc
 
AXSM Business Profile
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial for the treatment of Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. The company is also developing AXS-07 for the treatment of migraine; AXS-12 for the treatment of narcolepsy; and AXS-14 for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York. Address: 22 Cortlandt Street, New York, NY, United States, 10007
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service